MarketBeat.com | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Ironwood Pharmaceuticals Company Profile (NASDAQ:IRWD)

Consensus Ratings for Ironwood Pharmaceuticals (NASDAQ:IRWD) (?)
Ratings Breakdown: 5 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $17.11 (25.45% upside)

Current Analysts' Coverage Summary for Ironwood Pharmaceuticals (NASDAQ:IRWD)
Show:
DateFirmActionRatingPrice TargetActions
5/6/2015JPMorgan Chase & Co.Lower Price TargetOverweight$23.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Leerink SwannLower Price TargetMarket Perform -> Market Perform$17.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Cantor FitzgeraldReiterated RatingHold$13.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Bank of AmericaInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015BarclaysInitiated CoverageEqual Weight$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2015WallachBeth CapitalBoost Price TargetHold$15.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014Cowen and CompanyDowngradeOutperform -> Market Perform$16.00 -> $10.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2014Furey Research PartnersInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2014MizuhoBoost Price TargetBuy$17.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2014AegisReiterated RatingBuy -> PositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/10/2014BMO Capital MarketsUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2013Jefferies GroupLower Price TargetHold$12.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2013WedbushLower Price TargetNeutral$12.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013Goldman SachsInitiated CoverageSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2013Janney Montgomery ScottUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2013Credit SuisseInitiated CoverageOutperform$16.00 -> $11.31View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/2/2013 forward)